IGC Pharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $900.0K | $470.0K | $3.2M | $10.5M | $14.5M | $7.3M | $25.6M | $1.7M |
| Accounts Receivable | $12.0K | $39.0K | $107.0K | $125.0K | $175.0K | $133.0K | $84.0K | $558.0K |
| Inventory | $640.0K | $1.5M | $2.7M | $3.5M | $5.5M | $4.2M | $248.0K | $486.0K |
| Total Current Assets | $1.8M | $3.7M | $6.5M | $15.1M | $23.5M | $17.8M | $26.7M | $3.2M |
| Property, Plant & Equipment | $2.1M | $3.7M | $8.2M | $9.4M | $10.8M | $9.8M | $5.9M | $6.2M |
| Goodwill | — | — | — | — | — | — | — | $0 |
| Intangible Assets (Excl. Goodwill) | $5.1M | $1.6M | $1.2M | $917.0K | $407.0K | $252.0K | $184.0K | $128.0K |
| Total Assets | $9.7M | $9.9M | $17.2M | $26.8M | $35.9M | $29.0M | $34.5M | $10.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $773.0K | $530.0K | $981.0K | $476.0K | $762.0K | $319.0K | $258.0K |
| Total Current Liabilities | $2.2M | $2.3M | $1.9M | $2.4M | $2.4M | $1.9M | $878.0K | $2.3M |
| Long-Term Debt | $131.0K | $137.0K | $141.0K | $144.0K | $276.0K | $0 | — | — |
| Total Liabilities | $2.3M | $2.6M | $2.3M | $2.9M | $3.1M | $2.4M | $893.0K | $2.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-124.9M | $-113.7M | $-100.7M | $-89.2M | $-74.1M | $-65.4M | $-58.1M | $-53.8M |
| Total Stockholders' Equity | $7.4M | $7.3M | $14.9M | $23.9M | $32.8M | $26.5M | $33.6M | $8.1M |